Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 23 Dec 2025 for OptimizeRx Corp, €15k.
Insider track record
Disclosed buys
0
Disclosed sells
0
T+90 hit rate
67%
T+90 mean return
+41.9%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Theresa Greco: trading record in brief
This profile gathers the share dealings of Theresa Greco in OptimizeRx Corp. Between 1 November 2023 and 23 December 2025, the trades on record add up to 8 filings.
Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The newest entry dates from 23 December 2025: a share grant of €15k, in OptimizeRx Corp. Typically, a trade is published a median of 4 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Theresa Greco
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
1,420 shares@ US$12.74Common StockSEC:0001628280-25-058770:0
1,693 shares@ US$20.4978.9% of flowCommon StockSEC:0001628280-25-048472:0
15,625 shares0Common StockSEC:0001628280-25-041109:0
2,441 shares0Common StockSEC:0001628280-25-026500:0
15,528 shares0Common StockSEC:0001628280-24-052487:0
1,693 shares@ US$5.15100.0% of flowCommon StockSEC:0001628280-24-045424:0
18,519 shares0Common StockSEC:0001628280-23-036588:0
7 of 7 declarations
